Increased presence of amino-terminally-truncated Aβ-peptides in presenilin 1 early-onset familial Alzheimer disease

2000 ◽  
Vol 21 ◽  
pp. 194
Author(s):  
Claudio Russo ◽  
Takaomi C. Saido ◽  
Christine Hulette ◽  
Kathleen Price ◽  
Bernardino Ghetti ◽  
...  
2001 ◽  
Vol 299 (3) ◽  
pp. 239-241 ◽  
Author(s):  
Rosa Queralt ◽  
Mario Ezquerra ◽  
Magda Castellvı́ ◽  
Alberto Lleó ◽  
Rafael Blesa ◽  
...  

2014 ◽  
Vol 566 ◽  
pp. 115-119 ◽  
Author(s):  
Daniel Luedecke ◽  
Jos S. Becktepe ◽  
Jan T. Lehmbeck ◽  
Ulrich Finckh ◽  
Raina Yamamoto ◽  
...  

Neurogenetics ◽  
2002 ◽  
Vol 4 (2) ◽  
pp. 97-104 ◽  
Author(s):  
A. Bertoli Avella ◽  
B. Marcheco Teruel ◽  
J. Llibre Rodriguez ◽  
N. Gomez Viera ◽  
I. Borrajero Martinez ◽  
...  

1998 ◽  
Vol 18 (23) ◽  
pp. 9790-9799 ◽  
Author(s):  
Sherry Bursztajn ◽  
Richard DeSouza ◽  
Donna L. McPhie ◽  
S. A. Berman ◽  
Junichi Shioi ◽  
...  

2000 ◽  
Vol 57 (10) ◽  
Author(s):  
Gayatria Devi ◽  
Alexandra Fotiou ◽  
Darlene Jyrinji ◽  
Benjamin Tycko ◽  
Steve DeArmand ◽  
...  

2020 ◽  
Vol 2 (2) ◽  
Author(s):  
Md Al Rahim ◽  
Yonejung Yoon ◽  
Christina Dimovasili ◽  
Zhiping Shao ◽  
Qian Huang ◽  
...  

Abstract Excitotoxicity is thought to play key roles in brain neurodegeneration and stroke. Here we show that neuroprotection against excitotoxicity by trophic factors EFNB1 and brain-derived neurotrophic factor (called here factors) requires de novo formation of ‘survival complexes’ which are factor-stimulated complexes of N-methyl-d-aspartate receptor with factor receptor and presenilin 1. Absence of presenilin 1 reduces the formation of survival complexes and abolishes neuroprotection. EPH receptor B2- and N-methyl-d-aspartate receptor-derived peptides designed to disrupt formation of survival complexes also decrease the factor-stimulated neuroprotection. Strikingly, factor-dependent neuroprotection and levels of the de novo factor-stimulated survival complexes decrease dramatically in neurons expressing presenilin 1 familial Alzheimer disease mutants. Mouse neurons and brains expressing presenilin 1 familial Alzheimer disease mutants contain increased amounts of constitutive presenilin 1–N-methyl-d-aspartate receptor complexes unresponsive to factors. Interestingly, the stability of the familial Alzheimer disease presenilin 1–N-methyl-d-aspartate receptor complexes differs from that of wild type complexes and neurons of mutant-expressing brains are more vulnerable to cerebral ischaemia than neurons of wild type brains. Furthermore, N-methyl-d-aspartate receptor-mediated excitatory post-synaptic currents at CA1 synapses are altered by presenilin 1 familial Alzheimer disease mutants. Importantly, high levels of presenilin 1–N-methyl-d-aspartate receptor complexes are also found in post-mortem brains of Alzheimer disease patients expressing presenilin 1 familial Alzheimer disease mutants. Together, our data identify a novel presenilin 1-dependent neuroprotective mechanism against excitotoxicity and indicate a pathway by which presenilin 1 familial Alzheimer disease mutants decrease factor-depended neuroprotection against excitotoxicity and ischaemia in the absence of Alzheimer disease neuropathological hallmarks which may form downstream of neuronal damage. These findings have implications for the pathogenic effects of familial Alzheimer disease mutants and therapeutic strategies.


2001 ◽  
Vol 58 (6) ◽  
pp. 953 ◽  
Author(s):  
John C. Janssen ◽  
Peter L. Lantos ◽  
Nicholas C. Fox ◽  
Richard J. Harvey ◽  
Jonathan Beck ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document